{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:41:09Z","timestamp":1792572069041,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.47343","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T11:02:12Z","timestamp":1644404532000},"page":"e2147343","source":"Crossref","is-referenced-by-count":130,"title":["Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention"],"prefix":"10.1001","volume":"5","author":[{"given":"Gillian E.","family":"Hanley","sequence":"first","affiliation":[{"name":"Division of Gynaecologic Oncology, Department of Gynaecology and Obstetrics, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Vancouver General Hospital Research Pavilion, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste Leigh","family":"Pearce","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Talhouk","sequence":"additional","affiliation":[{"name":"Division of Gynaecologic Oncology, Department of Gynaecology and Obstetrics, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice S.","family":"Kwon","sequence":"additional","affiliation":[{"name":"Division of Gynaecologic Oncology, Department of Gynaecology and Obstetrics, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Finlayson","sequence":"additional","affiliation":[{"name":"Division of Gynaecologic Oncology, Department of Gynaecology and Obstetrics, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[{"name":"Division of Gynaecologic Oncology, Department of Gynaecology and Obstetrics, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[{"name":"Division of Gynaecologic Oncology, Department of Gynaecology and Obstetrics, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Pathology & Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Gynaecologic Oncology, Department of Gynaecology and Obstetrics, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"issue":"2, pt 1","key":"zoi211301r1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/AOG.0b013e31825f3576","article-title":"Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.","volume":"120","author":"Schrader","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"13","key":"zoi211301r2","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/cncr.31551","article-title":"Annual report to the nation on the status of cancer, part I: national cancer statistics.","volume":"124","author":"Cronin","year":"2018","journal-title":"Cancer"},{"issue":"4","key":"zoi211301r3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","article-title":"Population distribution of lifetime risk of ovarian cancer in the United States.","volume":"24","author":"Pearce","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"zoi211301r4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"zoi211301r5","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0959-8049(02)00269-1","article-title":"Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.","volume":"38","author":"Rebbeck","year":"2002","journal-title":"Eur J Cancer"},{"key":"zoi211301r6","article-title":"Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.","volume":"8","author":"Eleje","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"zoi211301r7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship.","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"zoi211301r8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The disparate origins of ovarian cancers: pathogenesis and prevention strategies.","volume":"17","author":"Karnezis","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"zoi211301r9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/01.AOG.0000459871.88564.09","article-title":"Committee opinion no. 620: salpingectomy for ovarian cancer prevention.","volume":"125","author":"American College of Obstetrics & Gynecology","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"6","key":"zoi211301r12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jogc.2016.12.005","article-title":"No. 344\u2014opportunistic salpingectomy and other methods of risk reduction for ovarian\/fallopian tube\/peritoneal cancer in the general population.","volume":"39","author":"Salvador","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"issue":"5","key":"zoi211301r13","doi-asserted-by":"publisher","first-page":"471.e1","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi211301r14","doi-asserted-by":"publisher","first-page":"172.e1","DOI":"10.1016\/j.ajog.2018.05.019","article-title":"Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.","volume":"219","author":"Hanley","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi211301r15","doi-asserted-by":"publisher","first-page":"221.e1","DOI":"10.1016\/j.ajog.2020.02.005","article-title":"Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.","volume":"223","author":"Hanley","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi211301r16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/AOG.0000000000000630","article-title":"Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.","volume":"125","author":"Kwon","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"zoi211301r17","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study.","volume":"107","author":"Falconer","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"zoi211301r18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2014.10.005","article-title":"Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma.","volume":"135","author":"Lessard-Anderson","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"zoi211301r19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/aogs.2014.94.issue-1","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"zoi211301r20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1757-2215-5-13","article-title":"Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis.","volume":"5","author":"Rice","year":"2012","journal-title":"J Ovarian Res"},{"issue":"12","key":"zoi211301r21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"issue":"1","key":"zoi211301r22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian cancer survival by histotype and disease stage.","volume":"111","author":"Peres","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"zoi211301r23","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jclinepi.2013.01.013","article-title":"Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research.","volume":"66","author":"Stuart","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"10290","key":"zoi211301r24","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"zoi211301r25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1006\/gyno.1998.5275","article-title":"The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?","volume":"72","author":"Dubeau","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"4","key":"zoi211301r26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/(ISSN)1096-9896","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"issue":"2","key":"zoi211301r27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"zoi211301r28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi211301r29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases.","volume":"31","author":"Tang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"zoi211301r30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1158\/1940-6207.CAPR-10-0266","article-title":"Microscopic and early-stage ovarian cancers in BRCA1\/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.","volume":"4","author":"Yates","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"zoi211301r31","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube.","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"zoi211301r32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"issue":"23","key":"zoi211301r33","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.1158\/1078-0432.CCR-17-0638","article-title":"Integrated analysis reveals tubal- and ovarian-originated serous ovarian cancer and predicts differential therapeutic responses.","volume":"23","author":"Hao","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"zoi211301r34","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"zoi211301r35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.","volume":"42","author":"Sieh","year":"2013","journal-title":"Int J Epidemiol"},{"key":"zoi211301r10","unstructured":"Royal College of Obstetricians & Gynaecologists. The distal fallopian tube as the origin of non-uterine pelvic high-grade serous carcinomas: scientific impact paper No. 44. November 2014. Accessed January 6, 2022. https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/scientific-impact-papers\/sip44hgscs.pdf"},{"key":"zoi211301r11","unstructured":"Society of Gynecologic Oncology. SGO clinical practice statement: salpingectomy for ovarian cancer. November 1, 2013. Accessed January 6, 2022. https:\/\/www.sgo.org\/resources\/sgo-clinical-practice-statement-salpingectomy-for-ovarian-cancer-prevention\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2788855\/hanley_2022_oi_211301_1643816429.55338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T11:02:18Z","timestamp":1644404538000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2788855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.47343","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741599544.793593451","asserted-by":"object"}]},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]}}}